Table 4.
Universal testing of all infants |
Testing known exposed |
|||||||
---|---|---|---|---|---|---|---|---|
44.7% of pregnant persons screened (base case) |
65% of pregnant persons screened |
90% of pregnant persons screened |
||||||
Outcome | Anti-HCV with reflex to HCV RNA at 18 months2,4 (Comparison) |
HCV RNA test at 2-6 months3,5 (Test Strategy 1) |
Anti-HCV with reflex to HCV RNA at 18 months2 (Test Strategy 2) |
HCV RNA test at 2-6 months3 (Test Strategy 3) |
Anti-HCV with reflex to HCV RNA at 18 months2 (Test Strategy 2) |
HCV RNA test at 2-6 months3 (Test Strategy 3) |
Anti-HCV with reflex to HCV RNA at 18 months2 (Test Strategy 2) |
HCV RNA test at 2-6 months3 (Test Strategy 3) |
Total costs (2021 USD) | 116,433,899 | 207,170,025 | 77,621,446 | 77,151,775 | 77,383,912 | 76,635,250 | 77,590,443 | 76,244,415 |
Testing outcomes | ||||||||
Tested infants | 2,709,916 | 3,076,918 | 4,478 | 7,588 | 6,466 | 10,993 | 8,918 | 15,221 |
Anti-HCV tests | 2,709,916 | 0 | 4,478 | 0 | 6,466 | 0 | 8,918 | 0 |
HCV RNA tests | 6,120 | 3,076,918 | 330 | 7,588 | 470 | 10,993 | 649 | 15,221 |
Epidemiologic outcomes among perinatally exposed infants | ||||||||
Diagnosed HCV infections | 553 | 971 | 254 | 443 | 362 | 632 | 498 | 875 |
HCC cases | 316 | 151 | 419 | 342 | 382 | 275 | 334 | 185 |
DCC cases | 334 | 157 | 463 | 388 | 416 | 305 | 356 | 197 |
Liver transplants | 58 | 28 | 74 | 62 | 68 | 50 | 62 | 34 |
HCV Liver-related deaths | 550 | 259 | 758 | 626 | 684 | 496 | 588 | 327 |
Treated/cured HCV infections | 438 | 775 | 196 | 347 | 284 | 501 | 393 | 698 |
Total QALYs | 694,546 | 696,669 | 693,059 | 694,026 | 693,590 | 694,967 | 694,319 | 696,221 |
Total Life-years | 1,814,939 | 1,826,061 | 1,807,109 | 1,812,187 | 1,809,846 | 1,817,052 | 1,813,710 | 1,823,653 |
Assumes 3.6 million births with 0.64% of births occurring among pregnant persons who are HCV RNA+.
Assumes 43.0% of children born to HCV RNA+ pregnant persons attend an 18-month visit.
Assumes 73.5% of children born to HCV RNA+ pregnant persons attend a 2-6 month visit.
Assumes 75.0% of children born to pregnant persons without HCV attend an 18-month visit.
Assumes 85.0% of children born to pregnant persons without HCV attend a 2-6 month visit.
Abbreviations: HCV, hepatitis C virus; anti-HCV, hepatitis C virus antibody; USD, United States Dollars; HCC, hepatocellular carcinoma; DCC, decompensated cirrhosis; QALYs, quality-adjusted life-years.